RankAlpha logo
Back to Rankings

NCNA

NuCanaD
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
View Chart
+
Peers tracked
8
U.S. public peers
Grade Position
In line
vs peer average
NCNA vs peer average
54/100
NCNA vs. peer average (D vs. D)
Grade spread
C 2 · D 2 · F 4
Graded peers loaded
Coverage
8 graded
100% of tracked

Peer overview

CURX is the first available peer comparator.

Same sector: Pharmaceuticals, Biotechnology & Life Sciences · Cap $6.67M

✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
Top peerCURXCuranex
NCNA
NuCana
CURX
Curanex
Grade
D
F
Momentum
16
10
Value
58
41
Sentiment
-
-
Setup Bias
Net —
-
Market Cap
-
-
Posture
Defensive
Defensive
Open Side-by-Side ComparisonCompare all

Grade position vs CURX

NCNA / CURX
Grade Position
In line
NCNA vs. peer average (D vs. D)
54/100
Momentum
16
NCNA
Value
58
NCNA
Sentiment
-
-

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank
Ticker
Company
Grade
Grade score
vs NCNA
1
CURX
Curanex Pharmaceuticals Inc Common
F
20/100
+1
2
NIKI
Niki BioSolutions Inc Common
F
20/100
+1
3
ERNA
Ernexa Therapeutics Inc Common
F
20/100
+1
4
ENVB
Enveric Biosciences Inc Common
C
60/100
-1
5
FBLG
FibroBiologics Inc Common
D
40/100
Even
CURX is the first peer returned for this comparison set.